CNTB
CNTB
NASDAQ · Biotechnology

Connect Biopharma Holdings L

$2.38
+0.00 (+0.00%)
As of Jun 30, 10:31 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +763.9% upside
Low Target $15.18
Average Target $20.56
High Target $23.56
Current Price $2.38
Current
$2.38
Target
$20.56
$15.18 $20.56 avg $23.56
Scenario Analysis
Bear Case
$15.18
537.8%
Low target
Base Case
$20.56
+763.9%
Avg target
Bull Case
$23.56
+889.9%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$3.82
-37.7% from high
52-Week Low
$0.91
+161.5% from low
Target vs 52W High
$20.56
+438.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%